Dr. Magda Marquet, Co-Founder & CEO, ALMA Life Sciences
Dr. Magda Marquet has built, led and commercialized multiple life science companies. She is the co-founder of AltheaDx, a commercial stage, precision medicine company and ALMA Life Sciences LLC, an early stage investment firm. She co-founded Althea Technologies and guided it to a successful acquisition by Ajinomoto, a global Japanese company. Prior to that, she held several positions in companies such as Vical and Amylin Pharmaceuticals. She is chairman of the board at Ajinomoto BioPharma Services and serves on public and private company boards including Arcturus Therapeutics, Pfenex and Senté. She received her Ph.D. in biochemical engineering from INSA/University of Toulouse, France.
